Application of PROTACs in target identification and validation

• Hauptverfasser: Yang Liu (Verfasst von), Jing Liang (Verfasst von), Rui Zhu (Verfasst von), Yueying Yang (Verfasst von), Yali Wang (Verfasst von), Wenyi Wei (Verfasst von), Hua Li (Verfasst von), Lixia Chen (Verfasst von)
• Format: Buch
• Veröffentlicht: Compuscript Ltd, 2024-03-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Proteolysis targeting chimeras (PROTACs), as a novel therapeutic drug model, has received widespread attention from academia and the pharmaceutical industry. PROTAC technology has led researchers to focus on developing chemical biology tool properties due to the unique operating mechanism and protei...